Table 2. Rates of MACE at 30 days, 6 months, 1-year, 2-year and 3-year follow-up.
| Cumulative 30-day rates (n = 1045) | |
| Death | 2 (0.19) |
| Cardiac | 2 (0.19) |
| Noncardiac | 0 |
| Nonfatal myocardial infarct | 2 (0.19) |
| Target lesion revascularization | 0 |
| All MACE | 4 (0.38) |
| Cumulative 6-month rates (n = 1035) | |
| Death | 7 (0.68) |
| Cardiac | 6 (0.58) |
| Noncardiac | 1 (0.10) |
| Nonfatal myocardial infarct | 5 (0.48) |
| Target lesion revascularization | 25 (2.42) |
| All MACE | 36 (3.48) |
| Cumulative 1-year rates (n = 1032) | |
| Death | 10 (0.97) |
| Cardiac | 8 (0.78) |
| Noncardiac | 2 (0.19) |
| Nonfatal myocardial infarct | 6 (0.58) |
| Target lesion revascularization | 46 (4.46) |
| All MACE | 60 (5.81) |
| Cumulative 2-year rates (n = 979) | |
| Death | 14 (1.43) |
| Cardiac | 12 (1.23) |
| Noncardiac | 2 (0.20) |
| Nonfatal myocardial infarct | 6 (0.61) |
| Target lesion revascularization | 53 (5.41) |
| All MACE | 71 (7.25) |
| Cumulative 3-year rates (n = 979) | |
| Death | 15 (1.53) |
| Cardiac | 13 (1.33) |
| Noncardiac | 2 (0.20) |
| Nonfatal myocardial infarct | 9 (0.92) |
| Target lesion revascularization | 58 (5.92) |
| All MACE | 80 (8.17) |
Values are numbers (%) of patients.
MACE, major adverse cardiac events.